Targeting Metabolic Dysfunction-Associated Steatotic Liver Disease: Innovations in Precision Medicine
Globally, the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) has reached alarmingly high levels, with over 30% of the ...